Employee Benefits 2024 Market Outlook

In 2023, employers were forced to confront new and enduring challenges, including rising healthcare costs, regulatory changes, ongoing high inflation, a competitive labor market, and growing employee demands. For many organizations, these challenges resulted in a difficult and demanding year. While many of these difficulties will likely continue through 2024 and beyond, understanding these challenges…

ACA Preventive Care Guidance and FAQs Following Braidwood Decision

On April 13, 2023, the Departments of Labor, Health and Human Services, and the Treasury (Departments) issued frequently asked questions (FAQs) regarding the Affordable Care Act’s (ACA) preventive care coverage requirement. The Departments issued these FAQs in response to a recent court decision from Texas (Braidwood Management Inc. v. Becerra) that invalidated a portion of…

Employee Benefits 2023 Market Outlook

The Employee Benefits Market Outlook examines critical employee benefits topics and trends, delivering insights into the market and forecasting where the industry may be headed in 2023 and beyond. Before addressing future trends, it’s critical to understand the central themes from 2022 that laid the groundwork for this year. To that end, the Market Outlook…

Employers Use Patient Assistance Programs to Offset Their Own Costs

DECEMBER 6, 2022 Anna Sutton was shocked when she received a letter from her husband’s job-based health plan stating that Humira, an expensive drug used to treat her daughter’s juvenile arthritis, was now on a long list of medications considered “nonessential benefits.†The July 2021 letter said the family could either participate in a new…

Behavioral Telehealth Loses Momentum Without a Regulatory Boost

  JANUARY 10, 2023 [UPDATED on Jan. 11] Controlled substances became a little less controlled during the pandemic. That benefited patients (for their health) and telehealth startups (to make money). Some potentially addictive medications — like buprenorphine and Adderall — are now far more available online to patients because of regulatory changes. Given the scarcity…